Incidence of immune checkpoint inhibitor-induced arthritis
- Conditions
- Solid tumors
- Registration Number
- JPRN-UMIN000044972
- Lead Sponsor
- Yokohama City University Graduate School of Medicine
- Brief Summary
Please refer to the following: Rheumatology (Oxford). 2022 Sep 7;keac519. doi: 10.1093/rheumatology/keac519. Online ahead of print.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14377
Not provided
(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (6) Studies with no or insufficient safety results at the time of the literature search. (7) Studies published in languages other than English.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method